"New" radiopharmaceuticals;Les « nouveaux » radiopharmaceutiques

Medecine Nucleaire

Volumn 32, Issue 8, 2008, Pages 456-461

  Payoux, P ^a   Alonso, M ^a   Esquerre J P ^a   Tafani, M ^a  

^a CHU PURPAN   (France)

Author keywords

Experimental medicine; French sanitary security and health products agency; Marketing authorization; Radiopharmaceuticals

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; ACETIC ACID C 11; ACETONITRILE; ALCOHOL; AMMONIA; CARBON 11; COLLOID TC 99M; COVIDIEN; DOPAMINE; FLUMAZENIL; FLUORIDE SODIUM; FLUORODEOXYGLUCOSE F 18; IAZODOPA; IODINE 123; KRYPTOSCAN; METHIONINE C 11; NITROGEN 13; OSTEOCIS; OXIDRONATE TECHNETIUM TC 99M; OXYGEN 15; OXYGEN 18; PENTETREOTIDE; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; SOLVENT; TRACER; WATER;

DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG MARKETING; DRUG PURIFICATION; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG USE; FRANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE ANALYSIS; LAW; MOLECULAR IMAGING; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; SHORT SURVEY;

EID: 49149116348     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mednuc.2008.06.007     Document Type: Short Survey

References (4)

1. Guilloteau D., Valat C.H., and Verbrugen A. Le médicament radiopharmaceutique : les alternatives à l'AMM. Médecine nucléaire, imagerie fonctionnelle et métabolique 29 (2005) 162-164
2. Afssaps. Bonnes pratiques de préparations en établissements de santé, en établissements médicosociaux et en officines de pharmacie, septembre 2006.
3. Afssaps. Bulletin officiel No 2007/7 bis. Fascicule spécial.
4. ® module on a medical research trial for hypoxic tissue evaluation in ischemic stroke ESRR'08 - European Symposium on Radiopharmacy and Radiopharmaceuticals, Skopje, Macedonia. Avril 2008.